Search bioRxivSearch

bioRxiv · 10.1101/788430

Pneumococcal attachment to epithelial cells is enhanced by the secreted peptide VP1 via its control of hyaluronic acid processing

Abstract

The Gram-positive bacterium Streptococcus pneumoniae (pneumococcus) is an important human pathogen. It can either asymptomatically colonize the nasopharynx or spread to other tissues to cause mild to severe diseases. Nasopharyngeal colonization is a prerequisite for all pneumococcal diseases. We describe a molecular pathway utilized by pneumococcus to adhere to host cells and promote colonization. We demonstrate that the secreted peptide VP1 enhances pneumococcal attachment to epithelial cells. Transcriptional studies reveal that VP1 triggers the expression of operons involved in the transport and metabolism of hyaluronic acid (HA), a glycosaminoglycan present in the host extracellular matrix. Genetic experiments in the pneumococcus reveal that HA processing locus (HAL) promotes attachment. Further, overexpression of HAL genes in the {Delta}vp1 background, reveal that the influence of VP1 on attachment is mediated via its effect on HA. In addition, VP1 also enhances degradation of the HA polymer, in a process that depends on the HAL genes. siRNA experiments to knockdown host HA synthesis support this conclusion. In these knockdown cells, attachment of wild-type pneumococci is decreased, and VP1 and HAL genes no longer contribute to the attachment. Finally, experiments in a murine model of colonization reveal that VP1 and HAL genes are significant contributors to colonization. Our working model, which combines our previous and current work, is that changes in nutrient availability that influence CodY and Rgg144 lead to changes in the levels of VP1. In turn, VP1 controls the expression of a genomic region involved in the transport and metabolism of HA, and these HAL genes promote adherence in an HA-dependent manner. VP1 is encoded by a core gene, which is highly induced in vivo and is a major contributor to host adhesion, biofilm development, colonization, and virulence. In conclusion, the VP1 peptide plays a central role in a pathway that connects nutrient availability, population-level signaling, adhesion, biofilm formation, colonization, and virulence.\n\nAUTHOR SUMMARYStreptococcus pneumoniae (the pneumococcus) is a major human pathogen. This bacterium asymptomatically colonizes the human upper respiratory tract from where it can disseminate to other tissues causing mild to severe disease. Colonization is a prerequisite for dissemination and disease, such that the molecules that control colonization are high-value candidates for therapeutic interventions. Pneumococcal colonization is a population-level response, which requires attachment to host cells and biofilm development. VP1 is a signaling peptide, highly induced in the presence of host cells and in vivo, promotes biofilm development, and serves as a potent virulence determinant. In this study, we build on the molecular mechanism of VP1 function to reveal novel bacterial and host molecules that enhance adherence and colonization. Our findings suggest that host hyaluronic acid serves as an anchor for pneumococcal cells, and that genes involved in the transport and metabolism of HA promote adherence. These genes are triggered by VP1, which in turn, is controlled by regulators that respond to nutrient status of the host. Finally, our results are strongly supported by studies in a murine model of colonization. We propose that VP1 serves as a marker for colonization and a target for drug design.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Cuevas, R. A., Elnaz Ebrahimi, E., Gazioglu, O., Yesilkaya, H., Hiller, N. L.. 2019-10-01. Pneumococcal attachment to epithelial cells is enhanced by the secreted peptide VP1 via its control of hyaluronic acid processing. https://doi.org/10.1101/788430

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology